Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

Neuro-oncology advances(2021)

引用 4|浏览10
暂无评分
摘要
https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000675-13/NL.
更多
查看译文
关键词
anti-Hu,antibodies,natalizumab,paraneoplastic neurological syndromes,treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要